The objective of this study was to determine the effect of the &adrenergic agonist cimaterol (C IM) on fiber characteristics, capillary supply, and metabolic enzyme activities in muscles of young Friesian bulls. In LM, the proportion of Type I (C: 24.0%, CIM: 20.4%; P < .07) and Type IIA fibers (C: 24.2%, CIM: 8.6%; P < .001) decreased, whereas the proportion of Type IIB fibers increased (C: 51.7%, CIM: 71.1%; P .001). Cimaterol increased the cross-sectional area of Type I ( P < .02) and Type IIB fibers ( P < .001), with no change in Type IIA fibers. Overall, the mean fiber area increased (C: 2,363 pm2, CIM: 3,934 pm2; P < . O O l ) . The number of capillaries per fiber did not change, but the number of capillaries per square millimeter decreased ( P < .001) after CIM treatment. Cimaterol changed metabolic enzyme activities toward lower oxidative capacity of the muscle (lactate dehydrogenase: +22%, hydroxyacyl-CoA dehydrogenase: -33%, and citrate synthetase: -34%; all P < .001) and reduced the glycogen content by 25% ( P < . O l ) .
Introduction
@-adrenergic agonists ( BAA) have been shown to induce muscle fiber hypertrophy of "white" fast-twitch muscle fibers of cattle (Miller et al., 1988; Maltin et al., 1990; Wheeler and Koohmaraie, 1992) and sheep (Kim et al., 1987) with no effects on fiber type proportion. However, a change in fiber type proportion has been reported after BAA treatment of sheep (Beermann et al., 1987) , swine (Oksbjerg et al., studies, the cross-sectional area occupied by white fast-twitch fibers is increased after BAA treatment.
Evidence also exists for a change in metabolic capacity of muscles from BAA-treated sheep and cattle toward more glycolytic and less oxidative metabolism Eisemann et al., 1988; Zimmerli and Blum, 1990) . Thus, BAA treatment may influence both contractile properties and general energy metabolism of the muscles.
Changes in muscle fiber characteristics and metabolic enzyme capacities have not previously been evaluated in combination in BAA-treated cattle. Moreover, effects on muscle fiber characteristics have not been studied over a wide range of developmental stages, and, finally, capillary supply in muscles of BAA-treated cattle has not been reported.
Therefore, the purpose of this study was to investigate the effect of cimaterol (CIM) on muscle fiber characteristics, capillary supply, glycogen content, and metabolic enzyme activities in longissimus ( LM) and semitendinosus ( ST) muscles sampled in vivo from fast-growing young Friesian bulls in three live weight groups.
Materials and Methods
Animals, Housing, Feeding, and Treatment. Details about animals, housing, feeding in the pre-treatment period, treatments, and production are given elsewhere (Vestergaard et al., 1993) . In short, 12 pairs of monozygotic twin Friesian bull calves weighing 100 to 120 kg were purchased for the experiment. The bulls were housed in an insulated barn and tied up pairwise in a sawdust-bedded stall. The stall was adjusted in length and width according to the actual size of the bull. In the pre-treatment period, bulls were pair-fed (with concentrate and small amounts of straw) according to live weight ( LW) of the smallest twin in the pair. The 12 pairs were allocated to three groups. The treatment period started when the pairs in these three weight groups (WG) reached a given weight. The mean LW at the start of treatment was 162, 299, and 407 kg (SEM = 2.3 kg) in WG I, 11, and 111, respectively. The age (mean f S E ) of the pairs was 205 k 10, 308 f 8, and 366 k 13 d a t start of the treatment period in WG I, 11, and 111, respectively. In the treatment period, bulls were scale-fed individually according to LW. The feeding intensity was planned to be 90% of the expected ad libitum intake. However, due to recent upward adjustments in feed intake capacities for young Friesian bulls (Ingvartsen, 19941 , the feeding intensity in WG I was approximately 80%. The feed consisted of a pelleted concentrate mixture and barley straw. The concentrate diet consisted of (weight basis) soybean meal (ll.O%), rolled oats (50.0%), rolled barley (31.5%), sugar beet molasses (5.0%), and vitamins and minerals (2.5%) according to Danish recommendations (Strudsholm et al., 1992) . The concentrate contained 16.3% crude protein and 12.2 MJ of MEkg of DM. For barley straw these figures were 5.3% and 5.1 MJ of MEkg of DM. Cimaterol was mixed in a pelleted concentrate mixture at 150 ppm. A pelleted placebo mixture was also prepared. These two mixtures contained 13.3% crude protein and 13.4 MJ of MEkg of DM. The treated twin of each pair was fed .06 mg of CIM.kg LW-l.d-l for 90 d (CIM), whereas the other twin received the placebo mixture and served as control. The CIM and placebo mixtures were fed twice daily in addition to the concentrate ration.
Bulls were reared in compliance with Danish regulations for the humane care and use of animals in research. The National Committee for Animal Experiments approved experimental protocols and supervised the experiments. The health of the bulls was monitored and sick bulls were treated by a veterinarian (Vestergaard et al., 1993) .
Sampling of Muscle Tissue. Six to eight days before slaughter (i.e., 82 to 84 d after initiation of treatment), needle biopsies were obtained from the LM and ST muscles. Live weight a t sampling was estimated from the two weekly weighings adjacent to the sampling date: 276 and 286 kg (C vs CIM) in WG I, 418 and 436 kg in WG 11, and 497 and 523 kg in WG I11 (SEM = 4 kg). The biopsy technique described by Lindholm and Piehl(1974) was used. The biopsy sites were localized and color-marked. The LM sample was taken at the last rib curvature approximately 5 to 8 cm lateral to the midline of the animal. The ST sample was collected approximately in the middle of the muscle (in both proximal-distal and medial-lateral directions). Both samples were taken from the right side of the animal and all samples were taken by the same person.
The skin was washed and cleaned with 70% ethanol. A local anesthesia ( 4 mL of 1% [wt/voll Carbocain, Nycomed DAK, Denmark) was applied and an incision approximately 10 mm long was made through the skin and the fascia overlying the muscle. The needle (0.d. 6 mm, Bergstrom, 1962) was inserted 2 to 3 cm into the middle portion of the muscle, and a 50-to 100-mg sample was removed. Aseptic procedures were observed during sampling. Wounds were powdered with neomycidbacitracin (Nebacitin, Lundbeck A / S , Denmark). No infection was detected after biopsy.
Preparation of Muscle Biopsy Samples. Muscle samples were divided into two equal parts for histochemical and biochemical analyses, respectively. The sample for histochemical analysis was embedded in OCT embedding media (Miles) and frozen in isopentane cooled in liquid nitrogen, and the sample for biochemical analysis was frozen in liquid nitrogen. The samples were stored a t -80°C until analysis. For classification of muscle fiber types and capillary supply, serial transverse sections ( 1 0 pm ) were cut in a cryostat (Leitz 1720 Digital, Wild Leitz, Denmark) at -20°C.
The fiber types were differentiated on the basis of pH sensitivity of the myosin ATPase (Brooke and Kaiser, 1970) . By this method, muscle fibers were classified into slow-twitch (Type I ) and fast-twitch fibers (Type IIA and Type IIB) after staining for myosin ATPase (pH 9.4) following preincubation in acid (pH 4.37 and 4.6) and alkaline (pH 10.3) media. The distinction between Type IIA and IIB fibers was made using the staining at pH 4.6, where Type IIA fibers appear white and Type IIB fibers appear grey. Very few fibers (less than 1%) had a staining intensity between Type IIA and Type IIB. Due to their low number, they were excluded from the analyses. Capillaries were visualized by the a-amylase-PASstain (Andersen, 1975) .
Histochemical Analysis. All histochemical analyses were performed on an interactive computerized image analysis system (Comfas, SCAN-BEAM, Hadsund, Denmark) designed for muscle fiber analyses (Henckel, 1989) . First, the section stained with a-amylase-PAS was placed under the microscope and displayed on a screen. Information about all visible capillaries, characterized as thickenings at the cell boundaries, was stored in the computer. Next, the ATPase-stained specimen was inserted, superimposed, and matched with the capillary network. From the computer software the following variables were calculated: 1) fiber type distribution in proportion and relative area, 2 ) cross-sectional area of individual fiber types and mean fiber area ( MF'A), 3 ) number of capillaries in contact with each fiber type and the mean fiber, 4 ) capillaries per square millimeter and the capillaries: fiber ratio, and, finally, 5) the diffusional property based on the ratio of MFA:capillaries in contact with the mean fiber. In LM samples 205 f 11 (mean k SE) fibers covering a cross-sectional area of .62 f .04 mm2 were analyzed per bull. In ST 213 f 12 fibers in 5 6 +_ .04 mm2 were analyzed per bull. Fiber type distribution varies within these two muscles, especially in ST (Totland et al., 1988) . Attempts were made to sample at the same anatomical site, which reduced variation between samples. However, extrapolation to the entire muscle should be made with caution, because the site does not necessarily represent the whole muscle.
Glycogen Content and Enzyme Activities.
Ten milligrams of tissue was homogenized for enzyme analyses after dilution to 1 : l O O in a .3 M potassium-phosphate buffer (pH 7.7 with .05% BSA). Tissue for determination of lactate dehydrogenase ( LDH) activity was diluted further to 1:440.
The samples for determination of glycogen were boiled for 2 h in .1 M HC1 to convert glycogen to glucose, and the glycogen content was expressed in glucose units. Glucose content, and the activity of LDH, citrate synthetase ( CS) , and L-3-hydroxyacylCoAdehydrogenase ( HAD) were all quantified by spectrophotometric methods using NADWADPH absorbance at 340 nm. The results are based on wet muscle weight. Glycogen content was expressed as micromoles/gram, LDH activity as millimoles.gram-l.minute-l, and CS and HAD activities as micromolesgram-1.minute-1.
Statistical Analysis. Data were analyzed separately for the two muscles. The statistical analysis was performed using the GLM procedures (SAS, 1985) appropriate for a split-plot design. Weight group (WG) was considered as the main plot (fixed effect) and was tested using twin pairs within WG (random effect) as the error term. The CIM (subplot) and WG x CIM interaction (both fixed effects) were tested against the residual (twin pairs x CIM [WGI) mean square term.
In one CIM-treated bull in WG 11, no Type IIA fibers were detected in either muscle. Because there were no Type IIA fibers in this bull, Type IIA fiber area and capillaries in contact with Type IIA fibers could not be calculated. Therefore this pair was excluded from the analysis ( n = 22). In another CIMtreated bull in WG 111, no good capillary stain of LM 'The statistical analysis included 22 observations (i.e., only three pairs in weight group 11). dThe weighted mean fiber area. eSEM is based on a sub-weight group of only three twin pairs.
could be made, and that twin pair was excluded from this analysis ( n = 22). For analyses with fewer than 24 observations, SEM for the sub-weight group with only three pairs is presented in the Tables.
Results
Muscle Differences. Semitendinosus and LM differ metabolically and histochemically; LM is more oxidative and ST is more "white" and contains mainly fasttwitch fibers. Furthermore, as shown by Beermann et al. (1987) and Totland et al. (1988) , LM is a relatively homogeneous muscle, whereas ST is relatively heterogenous in fiber type proportion between superficial, central, deep, medial, and lateral regions of the muscle. Also, there are differences between proximal, middle, and distal cross-sections. The samples in the present study were obtained from the "white" superficial-central region of the ST. The standard errors for the muscle fiber traits in ST were of the same magnitude as in LM (see Tables 1 and 21 , supporting our belief that all ST samples were obtained at a similar anatomical site.
Muscle Fiber Types and Fiber Areas. The proportion of Type I fibers tended to decrease in both muscles after CIM treatment (LM: P < .07; ST: P < .14; Tables   1 and 2 ). The most significant effect of CIM treatment was a reduction in the proportion of Type IIA fibers ( P < . O O l ) and an increase in the proportion of Type IIB fibers ( P < .001) in both muscles. In addition, Type I fiber area increased ( P < .02) in LM. There was a large increase in Type IIB fiber area in both LM and ST ( P < .001). Type IIA fiber area was unchanged in LM but slightly reduced in ST ( P < .12). Overall, CIM increased the mean fiber area (MFA) by 66% in LM ( P < .001) and by 42% in ST ( P < .001).
Due to the changes in fiber type proportions and individual fiber areas with CIM treatment, the relative areas of Types I and IIA fibers were reduced in both LM ( P < .002 and P < .001) and ST ( P < .004 and P < .001). Concomitantly, the relative area of Type IIB fibers was increased in both muscles ( P < .001).
The proportions of individual fiber types did not differ among weight groups. The area of the three fiber types, and hence the MFA, increased with increasing LW of the bulls (P-values between .08 and .008). However, due to the different hypertrophic response of the individual fiber types, the relative area of Type I fibers increased with LW in LM ( P < .02) and ST ( P < .02), whereas the relative area of Type IIB fibers decreased in LM ( P < .03) but not in ST ( P > .20) .
No significant CIM x WG interactions were detected for any of the muscle fiber traits. However, in ST Type I fiber area did not increase in WG I11 (CIM x WG interaction, P > .11). The longissimus muscle, containing more Type I and fewer Type IIB fibers than ST, responded more to CIM treatment than did ST.
Capillary Supply and Diffusion Properties. CIM treatment did not change the number of capillaries in V h e statistical analysis included 22 observations (i.e., only three pairs in weight group 11). dThe weighted mean fiber area. eThe SEM is based on a sub-weight group of only three twin pairs.
contact with Type I and Type IIB fibers, but the number of capillaries in contact with Type IIA fibers was reduced ( P < .02) in LM ( Table 3 ) . The ratio of capil1aries:fiber was unaffected by CIM, but, because of increased hypertrophy of fibers, the number of Capillaries per square millimeter decreased ( P < .001) in both muscles (Tables 3 and 4) . Hypertrophy of fibers with no change in capillary number led to a marked increase in the diffusional area in both muscles ( P < .002). There were no significant CIM x WG interactions and little influence of WG on the capillary traits. The exceptions were in LM, in which the capil1aries:fiber ratio increased ( P < .05) and the number of capillaries in contact with Type I fibers tended to increase with increasing LW ( P < .07). Due to the greater fiber hypertrophic response to CIM in LM, the diffusional properties of this muscle seemed to be affected more than in ST.
Glycogen Content and Enzyme Activities. Treatment with CIM reduced the glycogen content approximately 25% in both LM ( P < .002) and ST ( P < .001) (Table 5 1. In CIM-treated bulls the LDH activity was 22% higher in LM ( P < .003) but was unchanged in ST. The CS and HAD activities were reduced between 33 and 38% by CIM treatment (all P < .001). No CIM x WG interaction and no effect of WG were detected for the glycogen content or the three enzyme activities.
Discussion
CIM treatment slightly reduced the proportion of Type I fibers, markedly reduced the proportion of Type IIA fibers, and concomitantly increased the proportion of Type IIB fibers in both LM and ST muscles. Furthermore, there was a marked increase in the cross-sectional area of Type IIB fibers in both muscles after CIM treatment and a slight increase in the crosssectional area of Type I fibers in LM but not in ST. These changes suggest that muscles have a pool of labile Type IIA fibers susceptible to BAA treatment that were largely converted to Type IIB fibers. Another possible explanation for the conversion could be that initial Type I1 fiber hypertrophy leads to anoxic conditions that cause Type IIA fibers to be converted t o Type IIB. Oksbjerg et al. (1994a) have shown that conversion takes place within approximately 3 wk after BAA treatment is initiated in pigs. The conversion may be related t o a rapid alteration in muscle growth (Wang and Beermann, 1988; Pringle et al., 1993) and concurrent reduction in muscle protein degradation (Eisemann et al., 1988; Wheeler and Koohmaraie, 1992) . Finally, these changes seem to be consistent with the increased meat toughness after BAA treatment observed in the present (Vestergaard et al., 1994) and other studies (Hamby et al., 1986; Wheeler and Koohmaraie, 1992) .
These results, although more pronounced, agree with results found in pigs treated with the @-agonist salbutamol when the same staining procedure was used (Oksbjerg et al., 1990 (Oksbjerg et al., , 1994a . Also in agreement with our findings, Fiems et al. (1993) found Type IIA to Type IIB conversion in LM but detected no hypertrophic effects on the individual fibers in a study with finishing beef bulls. In other studies with ruminants, in which muscle fibers were classified into Types I and I1 fibers by myosin ATPase and(or) succinic dehydrogenase stains, selective Type I1 fiber hypertrophy was seen without changes in the proportion of Type I and I1 fibers (Kim et al., 1987; Miller et al., 1988) . However, in a study with lambs, Beermann et al. (1987) found a decreased proportion of Type I fibers in ST but not in LM or semimembranosus muscles and detected a marked hypertrophy of both Types I and I1 fibers in all three. Maltin et al. (1990) used a combined staining for four enzymes and found, in milk-fed calves, that clenbuterol caused marked hypertrophy of fast-twitch glycolytic ( FG) and fasttwitch oxidative-glycolytic ( FOG) fibers, but no changes in the fiber type proportions. Finally, Wheeler and Koohmaraie (1992) saw no change in the proportion of LM muscle fiber types in steers after treatment with the BAA L-644,969. However, PR fiber areas decreased and aR and aW were increased. Thus, independent of typing method, hypertrophy of "white fast-twitch fibers" was seen in most studies. Whereas the effect of BAA treatment on the proportion of fiber types is uncertain in the literature, we detected a conversion of Type IIA to Type IIB fibers. The muscle anabolic response after 90 d of CIM treatment was seen in both LM and ST (Vestergaard et al., 1993) . However, the most extensive fiber type hypertrophy and fiber type conversion were seen in LM, with a 66% increase in MFA compared with 42% increase in ST. Muscles with a different fiber type distribution also showed a different response to BAA treatment in other studies with cattle (Dawson et al., 1990; Maltin et al., 1990) but not to the same extent in sheep (Beermann et al., 1987; Kim et al., 1987) . Although Type IIA to Type IIB fiber conversion occurred in both muscles, the magnitude of response did not correlate to the proportion of Type IIA fibers, which was similar in both muscles (LM: 24.2%; ST: 24.3%). The response was more related to a lower proportion of Type IIB fibers (LM: 51.8%; ST: 61.8%) or a higher proportion of Type I fibers (LM: 24.0%; ST: 13.9%). However, the hypertrophic response in veal calves was greater in semimembranosus (10% slowoxidative [SO] and 68% FG fibers) than in triceps (25% SO and 41% FG fibers) muscles (Maltin et al., 1990) . Thus, the proportion of the different fiber types does not adequately explain the difference in responses between muscles. Dosage, type of P-agonist, and treatment duration are likely to affect muscle response and extent of fiber type conversion in all species. Furthermore, it cannot be excluded that a larger difference in animal's weight and(or) age than in the present study might affect the response to CIM treatment.
The potential role for endocrine factors in the transition of Type IIA to Type IIB fibers needs further investigation. Williams et al. (1984) found higher Padrenergic receptor density in slow-twitch oxidative than in fast-twitch mixed fiber muscles, but this does not seem to be associated with either fiber type conversion or selective fiber hypertrophy. @-adrenergic agonists are known t o affect glucocorticoid response at the tissue level by modulating receptor activity . Type I fibers have a higher density of glucocorticoid receptors (Dubois and Almon, 1984) and insulin receptors (Lefaucheur et al., 1986) than do Type I1 fibers. The effect of BAA may also be mediated via influence on the concentration, activity, or metabolism of hormones such as thyroxine (Scheidegger et al., 1984) , insulin (Webster et al., 1986; Vestergaard, 1991) , and glucocorticoids (Dumelow et al., 1991) .
Tone and activity of motor neurons could play a role in fiber type changes, oxidative capacity, and capillarization. However, capil1aries:fiber ratios were unchanged in this and another study (Oksbjerg et al., 1994a) . The reversal of denervation atrophy by clenbuterol treatment (Maltin et al., 1986; Zeman et al., 1987) suggests that the motor neurons are of little importance for muscle growth in this situation. On the other hand, it has been suggested that the mechanism of action of BAA in innervated and denervated muscles are different (Maltin et al., 1987) . Thus, the involvement of the motor neurons for the fiber type changes is not clear.
Because the number of capillaries was unaffected by CIM, the decrease in capillary density was due to fiber hypertrophy (Tables 3 and 4) . In growing pigs, capillarization of LM and biceps femoris muscles was unaffected by salbutamol treatment (Oksbjerg et al., 1994a) . The greater number of capillaries in contact with the smaller Type I (i.e., slow-twitch) fibers than with the larger Type IIB (i.e., fast-twitch) fibers might explain the fiber differences in energy metabolism and function.
Consequent to changed fiber type proportion by CIM treatment, the muscle oxidative potential was reduced (i.e., decreased CS and HAD activities), whereas the glycolytic potential (LDH activity) was increased in LM but not in ST muscles (Table 5 ) . Lactate dehydrogenase, an indicator of glycolytic capacity, is often associated with an increased proportion of fast-twitch fibers. Why LDH activity was not increased in ST muscles is unexplained; however, most of the effects seen were less pronounced in ST than in LM. Clenbuterol increased LDH activity in calf ST muscle (Zimmerli and Blum, 19901 , and CIM treatment increased lamb ST (anaerobic) and diaphragm (aerobic) muscle LDH activity . The decreased aerobic enzyme activity (CS and HAD) with CIM treatment as found in young bulls (this study), in calves (Zimmerli and Blum, 19901 , and in pigs (Oksbjerg et al., 1994b) coincides with a shift to increased non-oxidative metabolism. Increased non-oxidative metabolism was also seen in BAA-treated steers (Eisemann et al., 1988) . Indeed, Type I1 fibers are known to have lower oxidative gThe SEM is based on a sub-group of only three twin pairs.
metabolism than Type I fibers (Brooke and Kaiser, 1970; Ashmore et al., 1972) . The physiological impact of reduced mitochondrial pyruvate oxidative capacity could be a higher lactate production. Further support for this interpretation comes from the increased plasma lactate levels seen in BAA-treated sheep (Warriss et al., 1989) and pigs (Warriss et al., 19901 , enhanced lactate production from the hindquarter of BAA-treated steers (Eisemann et al., 19881 , and the higher lactate production in ovine muscle strips obtained from BAAtreated lambs (Hamby et al., 1986) . Reduced (?-oxidation capacity could lead to lower acetyl-coA production, which could decrease time to muscle exhaustion (Saltin and Rowell, 1980) . The CIM treatment reduced the glycogen content of both muscles. Similar findings were reported in other ruminant studies McEwan et al., 1985; Warriss et al., 1989) but not in pigs (Warriss et al., 1990; Oksbjerg et al., 1994b) . The increased size and proportion of fast-twitch muscle fibers correlates well with an apparent increased capacity to metabolize glycogen (Maltin et al., 1990) , utilize glucose, and form lactate in vitro (Hamby et al., 1986) . The enhanced anaerobic glycolysis with BAA treatment is in agreement with the elevation in LDH activity. Although glycogen synthesis might be increased in BAA-treated ruminants (Hamby et al., 1986) , glycogen content may be reduced if its stimulated breakdown exceeds its formation.
In conclusion, CIM treatment produced a marked hypertrophy of Type IIB fibers in growing bulls with extensive conversion of Type IIA to Type IIB fibers. The effects were seen in both LM and ST, and in all three weight groups. Combined with changes in metabolic enzymes from oxidative to more glycolytic activities, these findings suggest a major shift in muscle contractile and metabolic properties with CIM treatment.
Implications
These findings confirm that muscle hypertrophy in cattle treated with 0-adrenergic agonists is associated with hypertrophy of fast-twitch fibers. Furthermore, the results suggest a change in fiber type proportion and in muscle metabolism toward more glycolytic, less oxidative capacity. These findings imply that animals treated with @-adrenergic agonists might have a lower resistance to muscle fatigue. Finally, the changes in muscle histochemistry could be associated with the negative effects on meat tenderness seen with feeding 0-adrenergic agonists. Further studies are needed t o elucidate the nature of the fiber type transition.
